UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030555
Receipt number R000029988
Scientific Title Clinical trial of BNCT for skin malignancies
Date of disclosure of the study information 2017/12/26
Last modified on 2018/10/24 10:25:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical trial of BNCT for skin malignancies

Acronym

Clinical trial of BNCT for skin malignancies

Scientific Title

Clinical trial of BNCT for skin malignancies

Scientific Title:Acronym

Clinical trial of BNCT for skin malignancies

Region

Japan


Condition

Condition

skin malignant tumors

Classification by specialty

Dermatology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Clinical results of BNCT for patients with skin malignancies.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Local progression free survival rate

Key secondary outcomes

Early/late side effect


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

nuclear reactor (Kyoto University Research reactor)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Superficial malignancies is suitable for BNCR because of epi-thermal neutron being the less peretrating ability

Key exclusion criteria

Boron carrier compornent is not suitable for patients with renal disfunction.
Patients with metastasis is not eligible.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Junichi Hiratsuka

Organization

Kawasaki Medical School

Division name

Radiation Oncology

Zip code


Address

577 Matsushima, Kurashiki

TEL

086-462-1111

Email

hiratuka@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kawanishi

Organization

Kawasaki Medical School

Division name

Research Support

Zip code


Address

577 Matsushima, Kurashiki

TEL

086-462-1111

Homepage URL


Email

kenkyu-idai@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

the Japanese Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都大学原子炉実験所


Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 25 Day

Last modified on

2018 Year 10 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029988


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name